Role of Sodium-Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review

January 2025 in “ touchREVIEWS in Endocrinology ”

A B Kamrul-Hasan, Sunetra Mondal, Fatema Tuz Zahura Aalpona, Lakshmi Nagendra, Deep Dutta

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on touchendocrinology.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome

research Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome

8 citations , August 2023 in “The Journal of Clinical Endocrinology and Metabolism”

Follow the latest international guidelines to assess and manage Polycystic Ovary Syndrome effectively.

research Polycystic Ovary Syndrome: Insight Into Pathogenesis and a Common Association With Insulin Resistance

61 citations , June 2016 in “Clinical Medicine”

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

research Polycystic Ovary Syndrome: Insight Into Pathogenesis and a Common Association With Insulin Resistance

62 citations , December 2015 in “Clinical Medicine”

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).